{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:22:37Z","timestamp":1766514157197},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Metronidazole is widely used for treating infection of anaerobic bacteria and protozoa. Metronidazole is generally well tolerated, although metronidazole-associated peripheral neuropathy (PN) and metronidazole-induced encephalopathy (MIE) have been reported as rare side effects. The most common sites of MIE involve the bilateral dentate nucleus of the cerebellum. Herein, we present a rare case of MIE with isolated corpus callosum involvement, with concomitant metronidazole-associated PN.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A middle-aged man with ulcerative colitis was diagnosed with amoebic dysentery because of unhygienic eating. After receiving metronidazole (1.8\u200ag\/d, cumulative dose 61.2\u200ag) for &gt;1 month, he started to complain of continuous paresthesia of the limbs, and intermittent speech problems. Magnetic resonance imaging demonstrated an isolated lesion in the splenium of the corpus callosum.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>A diagnosis of reversible splenial lesion syndrome and PN was made. Given the patient's medical history, MIE and metronidazole-associated PN were considered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Metronidazole was stopped. Mecobalamine and vitamin B1 were used for adjuvant treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>At 1.5 months after stopping metronidazole, his symptoms of numbness and hyperesthesia had not improved, although he felt less ill. The isolated lesion disappeared on follow-up magnetic resonance imaging. At 6 months later, the hyperesthesia symptoms remained, and he was unable to resume his previous work.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Physicians should consider MIE in their differentials for reversible splenial lesion syndrome when encountering a patient with a history of metronidazole medication and symptoms of encephalopathy, especially with concomitant PN. Early identification of this metronidazole-related complication and early cessation of the drug are essential for treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000020198","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T15:57:00Z","timestamp":1589903820000},"page":"e20198","source":"Crossref","is-referenced-by-count":4,"title":["Isolated involvement of corpus callosum in metronidazole-induced encephalopathy with concomitant peripheral neuropathy"],"prefix":"10.1097","volume":"99","author":[{"given":"Qing","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"You","sequence":"additional","affiliation":[{"name":"Department of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Peking University First Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"R1-20240521","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/dkx351","article-title":"Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms","volume":"73","author":"Dingsdag","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"R2-20240521","first-page":"OE01","article-title":"Clinical and neuroradiological spectrum of metronidazole induced encephalopathy: our experience and the review of literature","volume":"10","author":"Roy","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R3-20240521","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijantimicag.2017.08.033","article-title":"Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature","volume":"51","author":"Goolsby","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"R4-20240521","article-title":"Metronidazole-induced encephalopathy: a systematic review","author":"Sorensen","year":"2018","journal-title":"J Neurol"},{"key":"R5-20240521","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/s-0037-1608779","article-title":"Mild encephalitis\/encephalopathy with reversible splenial lesion (MERS) due to cytomegalovirus: case report and review of the literature","volume":"49","author":"Feraco","year":"2018","journal-title":"Neuropediatrics"},{"key":"R6-20240521","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12883-017-0875-5","article-title":"Mild encephalitis\/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review","volume":"17","author":"Yuan","year":"2017","journal-title":"BMC Neurol"},{"key":"R7-20240521","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/WNF.0b013e3182334b35","article-title":"Metronidazole-induced central nervous system toxicity: a systematic review","volume":"34","author":"Kuriyama","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"R8-20240521","first-page":"272","article-title":"Radiographic evolution of a rapidly reversible leukoencephalopathy due to metronidazole","author":"Yoon Andrew Cho-Park","year":"2013","journal-title":"Neurology: Clinical Practice"},{"key":"R9-20240521","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RCT.0b013e31817e6f58","article-title":"Reversible inferior colliculus lesion in metronidazole-induced encephalopathy: magnetic resonance findings on diffusion-weighted and fluid attenuated inversion recovery imaging","volume":"33","author":"Lee S-HC","year":"2009","journal-title":"J Comput Assist Tomogr"},{"key":"R10-20240521","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jgf2.91","article-title":"Irreversible metronidazole encephalopathy in an elderly woman with primary biliary cholangitis","volume":"18","author":"Onuma","year":"2017","journal-title":"J Gen Fam Med"},{"key":"R11-20240521","doi-asserted-by":"crossref","first-page":"503596","DOI":"10.1155\/2014\/503596","article-title":"MR imaging findings in alcoholic and nonalcoholic acute Wernicke's encephalopathy: a review","volume":"2014","author":"Manzo","year":"2014","journal-title":"Biomed Res Int"},{"key":"R12-20240521","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/bmj.2.6087.610","article-title":"Metronidazole neuropathy","volume":"2","author":"Bradley","year":"1977","journal-title":"Br Med J"},{"key":"R13-20240521","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0003-9861(87)90577-7","article-title":"Enzymatic conversion of the antibiotic metronidazole to an analog of thiamine","volume":"257","author":"Abeles","year":"1987","journal-title":"Arch Biochem Biophys"},{"key":"R14-20240521","first-page":"512","article-title":"Metronidazole-induced encephalopathy: case report and review of MRI findings","volume":"00","author":"Jamsheed","year":"2011","journal-title":"Can J Neurol Sci"},{"key":"R15-20240521","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000085506","article-title":"Reversible visual deficit and Corpus callosum lesions due to metronidazole toxicity","volume":"53","author":"De Bleecker","year":"2005","journal-title":"Eur Neurol"},{"key":"R16-20240521","doi-asserted-by":"crossref","first-page":"11731","DOI":"10.1016\/S0021-9258(18)60872-5","article-title":"Generation of nitro radical anions of some 5-nitrofurans, 2- and 5-nitroimidazoles by norepinephrine","volume":"262","year":"1987","journal-title":"J Biol Chem"},{"key":"R17-20240521","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1939-1676.2003.tb02452.x","article-title":"Diazepam as a treatment for metronidazole toxicosis in dogs: a retrospective study of 21 cases","volume":"17","author":"Jason Evans","year":"2003","journal-title":"J Vet Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T20:09:24Z","timestamp":1716322164000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020198"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":17,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020198","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]}}}